GeoVax Labs, Inc. SEC filings GOVX

GeoVax Labs, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 5, 2008. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 27, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

GeoVax Labs, Inc. SEC filings
Form Description Filed Period
S-1 Registration statement Nov 4, 2026 —
8-K Current report
Shareholder vote results
Oct 27, 2026 Oct 27, 2026
8-K Current report
Material agreement, New debt, Change to shareholder rights, Officer or director change, Regulation FD disclosure
Oct 27, 2026 Oct 23, 2026
DRS/A Filing Oct 27, 2026 —
EFFECT Filing Sep 23, 2026 —
S-1 Registration statement Sep 17, 2026 —
DEF 14A Proxy statement Sep 10, 2026 Oct 27, 2026
8-K Current report
Other events
Sep 10, 2026 Sep 10, 2026
PRE 14A Preliminary proxy statement Aug 31, 2026 Oct 27, 2026
8-K Current report
Listing notice
Aug 28, 2026 Aug 27, 2026
8-K Current report
Material agreement, Unregistered share sale
Aug 28, 2026 Aug 25, 2026
DRS Filing Jul 30, 2026 —
10-Q Quarterly report Jul 27, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 27, 2026 Jul 27, 2026
8-K Current report
Listing notice
Jul 10, 2026 Jul 7, 2026
8-K Current report
Shareholder vote results
Jun 17, 2026 Jun 17, 2026
EFFECT Filing Jun 3, 2026 —
CORRESP Letter to the SEC Jun 1, 2026 —
UPLOAD Letter from the SEC Jun 1, 2026 —
S-1 Registration statement May 26, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 19, 2026 May 18, 2026
DEFR14A Form defr14a May 18, 2026 —
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
PRER14A Filing May 8, 2026 —
8-K Current report
Material agreement, Unregistered share sale
May 7, 2026 May 7, 2026
DEF 14A Proxy statement Apr 27, 2026 Jun 17, 2026
EFFECT Filing Apr 21, 2026 —
EFFECT Filing Apr 21, 2026 —
EFFECT Filing Apr 17, 2026 —
EFFECT Filing Apr 17, 2026 —
EFFECT Filing Apr 17, 2026 —
EFFECT Filing Apr 17, 2026 —
EFFECT Filing Apr 17, 2026 —
CORRESP Letter to the SEC Apr 17, 2026 —
CORRESP Letter to the SEC Apr 17, 2026 —
POS EX Form pos ex Apr 17, 2026 —
POS EX Form pos ex Apr 17, 2026 —
POS EX Form pos ex Apr 17, 2026 —
POS EX Form pos ex Apr 17, 2026 —
POS EX Form pos ex Apr 17, 2026 —
UPLOAD Letter from the SEC Apr 17, 2026 —
UPLOAD Letter from the SEC Apr 17, 2026 —
PRE 14A Preliminary proxy statement Apr 16, 2026 Jun 17, 2026
POS AM Filing Apr 16, 2026 —
POS AM Filing Apr 16, 2026 —
POS AM Filing Apr 16, 2026 —
POS AM Filing Apr 16, 2026 —
POS AM Filing Apr 16, 2026 —
S-1 Registration statement Apr 16, 2026 —
S-1 Registration statement Apr 16, 2026 —
8-K Current report
Results of operations
Apr 15, 2026 Apr 15, 2026
10-K Annual report Apr 15, 2026 Dec 31, 2025
8-K Current report
Material agreement, Unregistered share sale
Mar 31, 2026 Mar 31, 2026
NT 10-K Form nt 10-k Mar 31, 2026 Dec 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 17, 2026 Feb 13, 2026
424B5 Prospectus supplement Feb 17, 2026 —
424B5 Prospectus supplement Jan 26, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jan 12, 2026 Jan 9, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Dec 22, 2025 Dec 19, 2025
424B4 Prospectus Dec 22, 2025 —
EFFECT Filing Dec 19, 2025 —
CORRESP Letter to the SEC Dec 15, 2025 —
CORRESP Letter to the SEC Dec 15, 2025 —
S-1 Registration statement Dec 12, 2025 —
8-K Current report
Shareholder vote results
Nov 26, 2025 Nov 26, 2025
DRS Filing Nov 25, 2025 —
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
424B3 Prospectus Nov 13, 2025 —
424B3 Prospectus Nov 13, 2025 —
424B3 Prospectus Nov 13, 2025 —
424B3 Prospectus Nov 13, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
424B3 Prospectus Nov 7, 2025 —
S-1 Registration statement Oct 17, 2025 —
DEF 14A Proxy statement Oct 14, 2025 Nov 26, 2025
PRE 14A Preliminary proxy statement Oct 3, 2025 Nov 26, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 30, 2025 Sep 30, 2025
424B5 Prospectus supplement Sep 30, 2025 —
25-NSE Delisting notice Sep 29, 2025 —
424B5 Prospectus supplement Sep 19, 2025 —
8-K Current report
Listing notice
Aug 1, 2025 Jul 31, 2025
8-K Current report
Results of operations
Jul 29, 2025 Jul 28, 2025
424B3 Prospectus Jul 29, 2025 —
424B3 Prospectus Jul 29, 2025 —
424B3 Prospectus Jul 29, 2025 —
424B3 Prospectus Jul 29, 2025 —
424B3 Prospectus Jul 29, 2025 —
10-Q Quarterly report Jul 28, 2025 Jun 30, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jul 2, 2025 Jul 1, 2025
424B4 Prospectus Jul 2, 2025 —
EFFECT Filing Jun 30, 2025 —
CORRESP Letter to the SEC Jun 30, 2025 —
CORRESP Letter to the SEC Jun 27, 2025 —
S-1/A Amended registration statement Jun 26, 2025 —
CORRESP Letter to the SEC Jun 25, 2025 —
CORRESP Letter to the SEC Jun 23, 2025 —
CORRESP Letter to the SEC Jun 20, 2025 —
CORRESP Letter to the SEC Jun 17, 2025 —
S-1 Registration statement Jun 16, 2025 —
S-8 Employee stock plan registration Jun 6, 2025 —
8-K Current report
Shareholder vote results
Jun 5, 2025 Jun 5, 2025
DRSLTR Filing Jun 2, 2025 —
DRS Filing Jun 2, 2025 —
424B3 Prospectus May 1, 2025 —
424B3 Prospectus May 1, 2025 —
424B3 Prospectus May 1, 2025 —
424B3 Prospectus May 1, 2025 —
424B3 Prospectus May 1, 2025 —
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Agreement ended
Apr 14, 2025 Apr 11, 2025
DEF 14A Proxy statement Apr 14, 2025 Jun 5, 2025
EFFECT Filing Mar 28, 2025 —
EFFECT Filing Mar 28, 2025 —
EFFECT Filing Mar 28, 2025 —
EFFECT Filing Mar 28, 2025 —
EFFECT Filing Mar 28, 2025 —
PRE 14A Preliminary proxy statement Mar 28, 2025 Jun 5, 2025
8-K Current report
Results of operations
Mar 28, 2025 Mar 27, 2025
POS AM Form pos am Mar 27, 2025 —
POS AM Form pos am Mar 27, 2025 —
POS AM Form pos am Mar 27, 2025 —
POS AM Form pos am Mar 27, 2025 —
POS AM Form pos am Mar 27, 2025 —
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Mar 25, 2025 Mar 23, 2025
424B5 Prospectus supplement Mar 25, 2025 —
8-K Current report
Shareholder vote results
Jan 22, 2025 Jan 22, 2025
8-K Current report
Other events
Dec 18, 2024 Dec 18, 2024
8-K Current report
Listing notice
Nov 18, 2024 Nov 18, 2024
8-K Current report
Results of operations, Other events
Nov 13, 2024 Nov 12, 2024
424B3 Prospectus Nov 12, 2024 —
424B3 Prospectus Nov 12, 2024 —
424B3 Prospectus Nov 12, 2024 —
424B3 Prospectus Nov 12, 2024 —
424B3 Prospectus Nov 12, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Other events
Oct 16, 2024 Oct 16, 2024
8-K Current report
Other events
Oct 15, 2024 Oct 15, 2024
424B5 Prospectus supplement Oct 15, 2024 —
8-K Current report
Other events
Oct 1, 2024 Oct 1, 2024
8-K Current report
Material agreement
Sep 25, 2024 Sep 25, 2024
424B5 Prospectus supplement Sep 25, 2024 —
8-K Current report
Other events
Sep 17, 2024 Sep 17, 2024
EFFECT Filing Sep 13, 2024 —
EFFECT Filing Sep 13, 2024 —
CORRESP Letter to the SEC Sep 11, 2024 —
CORRESP Letter to the SEC Sep 11, 2024 —
UPLOAD Letter from the SEC Sep 10, 2024 —
UPLOAD Letter from the SEC Sep 10, 2024 —
S-1 Registration statement Sep 6, 2024 —
S-1 Registration statement Sep 6, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 30, 2024 Aug 28, 2024
424B5 Prospectus supplement Aug 30, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 21, 2024 Aug 20, 2024
424B5 Prospectus supplement Aug 21, 2024 —
EFFECT Filing Aug 12, 2024 —
CORRESP Letter to the SEC Aug 8, 2024 —
UPLOAD Letter from the SEC Aug 8, 2024 —
8-K Current report
Results of operations
Aug 7, 2024 Aug 6, 2024
424B3 Prospectus Aug 6, 2024 —
424B3 Prospectus Aug 6, 2024 —
424B3 Prospectus Aug 6, 2024 —
S-1 Registration statement Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
DEF 14A Proxy statement Aug 1, 2024 Sep 17, 2024
PRE 14A Preliminary proxy statement Jul 22, 2024 Sep 17, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 12, 2024 Jul 11, 2024
424B5 Prospectus supplement Jul 12, 2024 —
8-K Current report
Listing notice, Change to shareholder rights
Jun 21, 2024 Jun 20, 2024
EFFECT Filing Jun 18, 2024 —
8-K Current report
Material agreement
Jun 18, 2024 Jun 12, 2024
CORRESP Letter to the SEC Jun 14, 2024 —
UPLOAD Letter from the SEC Jun 14, 2024 —
S-1 Registration statement Jun 7, 2024 —
8-K Current report
Listing notice
May 24, 2024 May 23, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 23, 2024 May 23, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 21, 2024 May 16, 2024
424B5 Prospectus supplement May 21, 2024 —
8-K Current report
Results of operations
May 15, 2024 May 14, 2024
424B3 Prospectus May 14, 2024 —
424B3 Prospectus May 14, 2024 —
424B3 Prospectus May 14, 2024 —
424B3 Prospectus May 14, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
DEF 14A Proxy statement Apr 15, 2024 May 23, 2024
PRE 14A Preliminary proxy statement Apr 3, 2024 May 23, 2024
EFFECT Filing Mar 13, 2024 —
CORRESP Letter to the SEC Mar 11, 2024 —
10-K/A Amended annual report Mar 11, 2024 Dec 31, 2023
EFFECT Filing Mar 8, 2024 —
EFFECT Filing Mar 8, 2024 —
EFFECT Filing Mar 8, 2024 —
EFFECT Filing Mar 8, 2024 —
UPLOAD Letter from the SEC Mar 7, 2024 —
8-K Current report
Results of operations
Mar 1, 2024 Feb 29, 2024
S-3 Shelf registration Mar 1, 2024 —
POS AM Form pos am Mar 1, 2024 —
POS AM Form pos am Mar 1, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GOVX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Smyrna, GA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
832489
Former names
DAUPHIN TECHNOLOGY INC (until Sep 20, 2006)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.